Trial Profile
Study of Endostar Combined With Docetaxel and Cisplatin on the Angiogenesis of Advanced Non-small Cell Lung Cancer.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Docetaxel (Primary) ; Endostatin (Primary)
- Indications Non-small cell lung cancer
- Focus Registrational; Therapeutic Use
- 05 May 2008 New trial record.